NCT06380855Recruiting
Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
Sun Yat-sen UniversityClinicalTrials.govprocedure
Study focus
- Disease/Condition
- Rectal Cancer
- Drug/Device/Intervention
- Flexible colonoscope assisted hybrid transanal total mesorectal resection
- Study type
- Observational
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Sun Yat-sen University
- Location
- Guangzhou, China
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 24, 2022
- End date
- Aug 24, 2025
- Enrollment
- 5 participants
Primary outcome
Success rate of operation
Summary
The investigators propose to use flexible endoscopy combined with transanal total mesorectal
 resection to further reduce anal injury.
ICD-10 classifications
Malignant neoplasm of rectumCarcinoma in situ: RectumBenign neoplasm: RectumSecondary malignant neoplasm of large intestine and rectumCarcinoma in situ: Rectosigmoid junction
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06380855
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06380855 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 5 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.